Long-term efficacy and safety of idebenone in patients with LHON in the chronic phase: Results from the LEROS study

被引：0
|
作者：
Lloria, Xavier [1 ]
Tomasso, Livia [1 ]
Klopstock, Thomas [2 ]
机构：
[1] Chiesi Farmaceut SpA, Parma, Emilia Romagna, Italy
[2] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1581
引用
收藏
页数：3
相关论文
共 50 条
  • [31] LONG-TERM EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS: FINAL RESULTS FROM THE TAKT STUDY
    Nakaoka, Yoshikazu
    Yamashita, Katsuhisa
    Okada, Norihiro
    Yamakido, Shinji
    RHEUMATOLOGY, 2019, 58
  • [32] EFFICACY AND SAFETY OF RAMIPRIL IN COMBINATION WITH HYDROCHLOROTHIAZIDE - RESULTS OF A LONG-TERM STUDY
    HEIDBREDER, D
    FROER, KL
    BAUER, B
    CAIRNS, V
    BREITSTADT, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S169 - S173
  • [33] Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Comi, Giancarlo
    Kappos, Ludwig
    Hu, Xueqiang
    Xu, Xianhao
    Lublin, Alex L.
    Truffinet, Philippe
    Chavin, Jeffrey
    Delhay, Jean-Luc
    Benamor, Myriam
    Purvis, Annie
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [34] Long-term intracranial safety and efficacy analyses from the phase III CROWN study
    Bearz, A.
    Felip, E.
    Mazieres, J.
    de Marinis, F.
    Bauer, T.
    Polli, A.
    Messina, R.
    Thurm, H.
    Thomaidou, D.
    Mok, T. S. K.
    Solomon, B. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S998 - S999
  • [35] Assessing the impact of long-term idebenone treatment on various visual acuity outcomes in Leber's hereditary optic neuropathy (LHON): Results, according to primary mitochondrial DNA mutation, from the prospective, natural history-controlled LEROS study
    Tomasso, Livia
    Carelli, Valerio
    Yu-Wai-Man, Patrick
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [36] Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan Lewis
    Dolezil, David
    Silberstein, Stephen D.
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    CEPHALALGIA, 2020, 40 (06) : 543 - 553
  • [37] Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
    Song, Yuqin
    Zhou, Keshu
    Zou, Dehui
    Zhou, Jianfeng
    Hu, Jianda
    Yang, Haiyan
    Zhang, Huilai
    Ji, Jie
    Xu, Wei
    Jin, Jie
    Lv, Fangfang
    Feng, Ru
    Gao, Sujun
    Guo, Haiyi
    Zhou, Lei
    Huang, Jane
    Novotny, William
    Kim, Pil
    Yu, Yiling
    Wu, Binghao
    Zhu, Jun
    BLOOD, 2022, 139 (21) : 3148 - 3158
  • [38] Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
    Rostaing, L.
    Vincenti, F.
    Grinyo, J.
    Rice, K. M.
    Bresnahan, B.
    Steinberg, S.
    Gang, S.
    Gaite, L. E.
    Moal, M-C
    Mondragon-Ramirez, G. A.
    Kothari, J.
    Pupim, L.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2875 - 2883
  • [39] Results of a Long-Term Efficacy and Safety Study of Viltolarsen in the Treatment of Duchenne Muscular Dystrophy Patients
    Rao, V
    Clemens, P.
    Connolly, A.
    Harper, A.
    Mah, J.
    Smith, E.
    McDonald, C.
    Zaidman, C.
    Nakagawa, T.
    Hoffman, E.
    ANNALS OF NEUROLOGY, 2021, 90 : S92 - S92
  • [40] Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
    Wong, Raymond S. M.
    Saleh, Mansoor N.
    Khelif, Abderrahim
    Salama, Abdulgabar
    Portella, Maria Socorro O.
    Burgess, Paul
    Bussel, James B.
    BLOOD, 2017, 130 (23) : 2527 - 2536
12345